Tower Research Capital LLC (Trc) Maia Biotechnology, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,026 shares of MAIA stock, worth $4,187. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,026
Previous 1,847
117.98%
Holding current value
$4,187
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding MAIA
# of Institutions
21Shares Held
2.35MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.1MShares$1.15 Million0.0% of portfolio
-
Centric Wealth Management575KShares$597,8930.21% of portfolio
-
Geode Capital Management, LLC Boston, MA271KShares$281,8980.0% of portfolio
-
Marshall Wace, LLP London, X0110KShares$114,8850.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$81,6610.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $11.4M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...